Sign in
4

Changes in Ownership

Matinas BioPharma Holdings, Inc. Filed Acc 0001493152-22-036236

Options or other derivatives

  • President and CEO acquired 1,988,300 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Jabbour Jerome D President and CEO 2022-12-20 Grant or award · Stock Option (right to Buy) +1,988,300 1,988,300 D: show line 1 in the form
Loading xslF345X03/ownership.xml…